tiprankstipranks
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market
FBIO
Fortress Biotech
RESEARCH TOOLSreports
Want to see FBIO full AI Analyst Report?

Fortress Biotech (FBIO) Ratios

1,595 Followers

Fortress Biotech Ratios

FBIO's free cash flow for Q2 2026 was $0.62. For the 2026 fiscal year, FBIO's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.96 2.49 1.27 1.38 1.80
Quick Ratio
 3.83 2.30 1.06 1.26 1.69
Cash Ratio
 3.17 1.60 0.80 0.95 1.40
Solvency Ratio
 1.06 0.09 -0.28 -0.33 -0.32
Operating Cash Flow Ratio
 2.03 -1.32 -1.12 -1.51 -1.40
Short-Term Operating Cash Flow Coverage
 17.38 0.00 -128.31 -13.56 -17.62
Net Current Asset Value
$ 134.88M$ 476.00K$ -55.50M$ -48.92M$ -13.84M
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.40 0.53 0.53 0.43
Debt-to-Equity Ratio
 0.39 1.49 3.34 3.93 3.05
Debt-to-Capital Ratio
 0.28 0.60 0.77 0.80 0.75
Long-Term Debt-to-Capital Ratio
 0.22 0.54 0.72 0.73 0.69
Financial Leverage Ratio
 1.93 3.72 6.34 7.43 7.05
Debt Service Coverage Ratio
 9.57 -2.24 -9.93 -6.20 -8.15
Interest Coverage Ratio
 -3.27 -8.06 -11.12 -11.37 -14.92
Debt to Market Cap
 0.64 0.58 1.39 2.88 1.76
Interest Debt Per Share
 2.33 2.98 4.13 12.47 23.80
Net Debt to EBITDA
 -0.82 0.25 -0.18 -0.06 0.26
Profitability Margins
Gross Profit Margin
62.53%66.92%63.80%72.91%59.37%
EBIT Margin
226.10%-39.24%-188.91%-167.69%-268.07%
EBITDA Margin
233.38%-31.88%-181.17%-160.59%-255.73%
Operating Profit Margin
-42.86%-111.00%-191.38%-168.43%-268.76%
Pretax Profit Margin
213.00%-53.01%-209.00%-181.79%-281.83%
Net Profit Margin
163.32%10.77%-79.75%-71.75%-114.30%
Continuous Operations Profit Margin
206.22%-52.03%-209.54%-182.40%-282.42%
Net Income Per EBT
76.67%-20.32%38.16%39.47%40.56%
EBT Per EBIT
-496.98%47.76%109.21%107.93%104.86%
Return on Assets (ROA)
35.31%3.67%-31.89%-36.20%-29.42%
Return on Equity (ROE)
103.52%13.66%-202.30%-268.97%-207.51%
Return on Capital Employed (ROCE)
-11.52%-51.71%-151.57%-172.29%-122.20%
Return on Invested Capital (ROIC)
-10.85%-49.97%-145.10%-154.60%-113.59%
Return on Tangible Assets
38.40%4.31%-40.94%-41.18%-32.41%
Earnings Yield
140.12%6.67%-109.02%-248.37%-147.59%
Efficiency Ratios
Receivables Turnover
 1.86 2.11 5.54 5.49 2.67
Payables Turnover
 2.16 1.47 0.66 0.66 0.54
Inventory Turnover
 3.15 2.17 1.45 2.24 2.17
Fixed Asset Turnover
 4.97 4.27 3.37 3.60 2.29
Asset Turnover
 0.22 0.34 0.40 0.50 0.26
Working Capital Turnover Ratio
 0.36 1.36 2.26 1.25 0.44
Cash Conversion Cycle
 143.28 92.26 -234.94 -325.82 -374.40
Days of Sales Outstanding
 195.93 172.75 65.83 66.46 136.60
Days of Inventory Outstanding
 116.06 167.88 252.28 162.72 167.93
Days of Payables Outstanding
 168.70 248.37 553.05 555.00 678.93
Operating Cycle
 311.98 340.63 318.11 229.18 304.53
Cash Flow Ratios
Operating Cash Flow Per Share
 3.98 -2.36 -3.86 -15.81 -30.28
Free Cash Flow Per Share
 3.97 -2.36 -4.58 -16.81 -30.79
CapEx Per Share
 <0.01 0.00 0.72 1.00 0.52
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.19 1.06 1.02
Dividend Paid and CapEx Coverage Ratio
 228.12 -99.06 -4.07 -7.60 -15.16
Capital Expenditure Coverage Ratio
 1.59K 0.00 -5.35 -15.83 -58.72
Operating Cash Flow Coverage Ratio
 1.94 -0.89 -1.06 -1.45 -1.41
Operating Cash Flow to Sales Ratio
 1.84 -1.04 -1.39 -1.52 -2.37
Free Cash Flow Yield
150.33%-64.41%-225.62%-558.38%-311.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 0.77 -54.30 -0.75 -0.40 -0.68
Price-to-Sales (P/S) Ratio
 1.22 1.61 0.73 0.29 0.77
Price-to-Book (P/B) Ratio
 0.49 2.05 1.86 1.08 1.41
Price-to-Free Cash Flow (P/FCF) Ratio
 0.67 -1.55 -0.44 -0.18 -0.32
Price-to-Operating Cash Flow Ratio
 0.63 -1.55 -0.53 -0.19 -0.33
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.56 0.01 <0.01 -0.03
Price-to-Fair Value
 0.49 2.05 1.86 1.08 1.41
Enterprise Value Multiple
 -0.30 -4.81 -0.58 -0.24 -0.04
Enterprise Value
 -48.08M 97.04M 60.89M 32.08M 7.74M
EV to EBITDA
 -0.30 -4.81 -0.58 -0.24 -0.04
EV to Sales
 -0.70 1.53 1.06 0.38 0.10
EV to Free Cash Flow
 -0.38 -1.48 -0.64 -0.24 -0.04
EV to Operating Cash Flow
 -0.38 -1.48 -0.76 -0.25 -0.04
Tangible Book Value Per Share
 5.70 1.24 -1.61 -2.31 3.85
Shareholders’ Equity Per Share
 5.18 1.79 1.09 2.78 7.04
Tax and Other Ratios
Effective Tax Rate
 0.03 0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
 2.16 2.27 2.77 10.42 12.78
Net Income Per Share
 3.53 0.24 -2.21 -7.48 -14.61
Tax Burden
 0.77 -0.20 0.38 0.39 0.41
Interest Burden
 0.94 1.35 1.11 1.08 1.05
Research & Development to Revenue
 0.02 0.19 0.99 1.26 1.78
SG&A to Revenue
 1.01 1.52 1.52 0.00 0.00
Stock-Based Compensation to Revenue
 0.08 0.45 0.57 0.20 0.30
Income Quality
 1.11 2.00 0.66 0.83 0.84
Currency in USD